Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets close in 7 hours 59 minutes
FTSE 100
8,191.57
+19.42
(+0.24%)
FTSE 250
20,059.52
+7.19
(+0.04%)
AIM
769.65
+1.54
(+0.20%)
GBP/EUR
1.1690
+0.0007
(+0.06%)
GBP/USD
1.2545
+0.0012
(+0.09%)
Bitcoin GBP
47,348.09
+1,333.01
(+2.90%)
BridgeBio Pharma, Inc. (BBIO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
27.74
+0.71
(+2.63%)
At close: 04:00PM EDT
26.75
-0.99
(-3.57%)
After hours:
05:43PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
9,303
9,303
77,648
69,716
8,249
Cost of revenue
2,446
2,446
3,434
3,114
0
Gross profit
6,857
6,857
74,214
66,602
8,249
Operating expenses
Research development
455,711
455,711
399,462
451,024
337,047
Selling general and administrative
150,590
150,590
143,189
192,210
145,684
Total operating expenses
606,301
606,301
542,651
643,234
482,731
Operating income or loss
-599,444
-599,444
-468,437
-576,632
-474,482
Interest expense
81,289
81,289
80,438
46,778
36,655
Total other income/expenses net
9,444
9,444
56,681
35,823
1,634
Income before tax
-653,251
-653,251
-484,652
-586,454
-505,488
Income from continuing operations
-653,251
-653,251
-484,652
-586,454
-505,488
Net income
-643,202
-643,202
-481,183
-562,539
-448,724
Net income available to common shareholders
-643,202
-643,202
-481,183
-562,539
-448,724
Basic EPS
-3.91
-
-3.26
-3.90
-3.80
Diluted EPS
-3.91
-
-3.26
-3.90
-3.80
Basic average shares
156,510
-
147,473
144,357
117,995
Diluted average shares
156,510
-
147,473
144,357
117,995
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.